Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06414798
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-10
Brief Title:
A Study to Assess the Safety Tolerability and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Participants
Sponsor:
AbbVie
Organization:
AbbVie
Study Overview
Official Title:
A First-in-Human Single Ascending Dose and Mass Balance Study to Evaluate the Safety Tolerability and Pharmacokinetics of ABBV-1088 in Healthy Adult Subjects
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the single dose safety tolerability and pharmacokinetic properties of ABBV-1088 in healthy adult participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None